Clinical Trial

Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this post-market registry is to assess the clinical use of the Lifetech CeraFlex™ Closure System in a real-world and on-label fashion.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2023-05-24; most recent amendment 2026-05-21.
Status change: Not Yet Recruiting → Recruiting 2024-09-24
Trial Details
NCT Number NCT05887700
Lead Sponsor Lifetech Scientific (Shenzhen) Co., Ltd.
Conditions Atrial Septal Defect
Enrollment 145 participants
Start Date 2024-07-09
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-26